A comparative biochemical study on the non diabetic obese and non obese subjects with cardiovascular disease

M. Prasad Naidu, S. V. Prasad, B. Madhusudan Reddy, Sujith Tumkur Rajasekar, P. Aruna


Cardiovascular disease is now a major public health problem in India and is emerging as a major killer. The non diabetic obese and non obese subjects with cardio vascular disease” were carried out with the objective of studying or investing the (effect) cause of cardiovascular diseases in obese and Non-obese subjects. The level of lipoprotein a of non obese subject showed a significant (P < 0.001) increase than in the obese subject. The level of lipid ratio (total cholesterol / HDL cholesterol) found to be significantly (P < 0.001) high in obese subjects than in non-obese subjects. The present study has been designed to evaluate or investigate the risk of cardiovascular disease due to obesity in both male and female middle age group.


Obesity, Lipoprotein, Homocysteine, Cholesterol, Diabetes mellitus

Full Text:



Kanani.P.M, Sinkey.C.A, Browing.R.L, Allaman.M, Knapp.H.R, Haynes. W.G (1999), Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst (e) inemmia in humans, circulation, 100: 1161- 1168.

Florentio.R.F. (2000), The Burden of obesity in Asia challenges in Assements, prevention and Management, Asia pacific journal of clinical nutrition, 11,676-680.

McCully. K.S, (1969), vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis, Am J Pathol.56:111-128.

Liaugaudas.G Jacques P.F, Selhub. J, Rosenberg. IH, Bostom. A.G, (2001). Renal insuffuciency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscl Thromb Vasc Biol, 21:849-851.

Den Heijer.M, Keijzer.M.B, (2001). Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med.39: 710-713.

Manson.J.E, Coldite. G.A, Stampfer. M.J, Willett. W.C, Rosner. B, Manson. R.R, speizer. F.E. Hennekens. C.H.(1990), A prospective study of obesity and risk of coronary heart disease in women, New. Eng.J.Med, 29: 882-889.

Despres. J.P, Nadeau. A, Tremblay A, Ferland.M, Moorjani. S, Lupien.P.J, Teriault.G, Pinault.S, Bouchard.C (1989), glucose tolerence in obese women Diabetes 30:304-309.

K.jorntrop. P (1990) “ Portal” adipose tissue as a generator of risk factor for cardiovascular disease and diabetic, Arteriosclerosic, 10: 493-496.

Klein. B.E.K, Klein.R, Lee. K.E. (2002) components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam, Diabetes care, 25 (10), 1790- 1794.

Gordon. D.J and Rifkind. B.M. (1989), High density lipoprotein – The clinical implications of recent studies, 321(19), 1311-1316.

Miller. M, Seidler. A, Kwiterovich. P. Coronary artery disease and “desirable” levels of plasma total cholesterol. Circulation 1992;86:1165-1170.

Jeppesen.J, Hein.H.O, Sudicanl. P, Gyntelberg.F. (2001), Low triglcerides- High High-density lipoprotein cholesterol and risk of ischemic heart disease, Arch. Intern.Med, 161(12), 361-366.

Huttunens. J.K, Lansimies. E, Voutilanies. E. Effect of moderate physical exercise on serum lipoproteins, Circulation 1979;60:1220-1229.

Mensink. R.P, Katan. M.B. Effect of dietary fatty acids on serum lipids and lipoproteins, Arterioscler Thromb 1992;12:1911-1919.

Bergland T, Ramakrishna R. Lipoprotein(a) A exclusive cardiovascular risk factor. J Arteriosclerosis, Thrombosis and Vascular Biology 2004;24:2219.

Bailey DL, Meikle SR. A convolution-subtraction scatters correction method for 3D PET. Phys Med Biol 1994;39(3):411-24.